CHIBROXIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chibroxin, and what generic alternatives are available?
Chibroxin is a drug marketed by Merck and is included in one NDA.
The generic ingredient in CHIBROXIN is norfloxacin. There are seven drug master file entries for this compound. Additional details are available on the norfloxacin profile page.
US Patents and Regulatory Information for CHIBROXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | CHIBROXIN | norfloxacin | SOLUTION/DROPS;OPHTHALMIC | 019757-001 | Jun 17, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CHIBROXIN
See the table below for patents covering CHIBROXIN around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Australia | 3271378 | ⤷ Start Trial | |
| Australia | 512940 | ⤷ Start Trial | |
| Belgium | 863429 | ⤷ Start Trial | |
| Canada | 1178961 | DERIVES DE L'ACIDE QUINOLINE-CARBOXYLIQUE (QUINOLINE CARBOXYLIC ACID DERIVATIVE) | ⤷ Start Trial |
| Germany | 2804097 | ⤷ Start Trial | |
| France | 2391210 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
